Mathes Company’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.05M Sell
42,853
-80
-0.2% -$6.31K 1.11% 28
2025
Q4
$3.52M Sell
42,933
-4,421
-9% -$344K 1.26% 24
2025
Q3
$3.56M Buy
47,354
+907
+2% +$67.7K 1.28% 24
2025
Q2
$3.44M Sell
46,447
-1,081
-2% -$75.3K 1.28% 25
2025
Q1
$3.84M Sell
47,528
-643
-1% -$55.3K 1.56% 25
2024
Q4
$3.77M Sell
48,171
-1,080
-2% -$91.8K 1.37% 26
2024
Q3
$4.62M Buy
49,251
+32,665
+197% +$2.74M 1.63% 21
2024
Q2
$1.29M Buy
16,586
+1,416
+9% +$115K 0.47% 54
2024
Q1
$1.38M Sell
15,170
-97
-0.6% -$8.07K 0.52% 51
2023
Q4
$1.18M Buy
15,267
+50
+0.3% +$3.5K 0.49% 55
2023
Q3
$1.03M Buy
15,217
+4,487
+42% +$326K 0.48% 57
2023
Q2
$872K Buy
+10,730
New +$856K 0.38% 61

Other funds holding GEHC

Mathes Company's GEHC Position: Q1 2026 in Review

Mathes Company reduced its GE HealthCare (GEHC) stake by 0.19% in Q1 2026, selling an estimated $6.31K and leaving 42,853 shares worth $3.05M. The position accounts for 1.11% of the portfolio, ranked #28.

Mathes Company first reported a position in GEHC in Q2 2023 and has held it in 12 quarters since. The position peaked at $4.62M in Q3 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Mathes Company held 42,853 shares of GE HealthCare worth $3.05M as of Q1 2026.
  • Mathes Company sold 80 GE HealthCare shares in Q1 2026, an estimated $6.31K.
  • GE HealthCare made up 1.11% of Mathes Company's portfolio in Q1 2026, its #28 holding.
  • Mathes Company first reported a position in GE HealthCare in Q2 2023 and has held it in 12 quarters since.
  • Mathes Company's GE HealthCare position peaked at $4.62M in Q3 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Mathes Company's 13F filing for Q1 2026, filed 8 May 2026.